Latest News

Older age for menopause raises risk for lung cancer


 

Limitations

The main limitation of the MR study was the potential for inadequate power for assessing some outcomes despite the large overall size of the study cohort. Lack of adequate power may be responsible for some of the nonsignificant associations seen in the study, such as for breast and endometrial cancers, where substantial prior evidence has implicated increased risk through the effects of prolonged exposure to endogenous or exogenous estrogens.

The healthy cohort effect in the UKB is a known weakness of this dataset that may have limited the number of cases and generalizability of findings.

Osteoporosis and Alzheimer’s disease were self-reported.

The study only included participants of European ancestry because most subjects in most of the cohorts examined were White women and the applied MR instruments were found by genome-wide association studies run predominantly in White women. The authors said the causal effects of ANM need study in more diverse populations.

Disclosures

  • The study received no commercial funding.
  • None of the authors had disclosures.

This is a summary of a preprint research study, “Genetic evidence for causal relationships between age at natural menopause and the risk of aging-associated adverse health outcomes,” written by authors primarily based at Stanford University School of Medicine i

A version of this article first appeared on Medscape.com.

Pages

Recommended Reading

Monotherapy or one-two punch against EGFR-mutant NSCLC?
MDedge Hematology and Oncology
ICIs for NSCLC: Patients with ILD show greater risk
MDedge Hematology and Oncology
“I didn’t want to meet you.” Dispelling myths about palliative care
MDedge Hematology and Oncology
New PET tracer detects more metastases in cancer patients
MDedge Hematology and Oncology
E-cigarettes don’t help smokers quit, suggests new research
MDedge Hematology and Oncology
Earlier diagnosis could prevent more than 20% of cancer deaths
MDedge Hematology and Oncology
Black patients now central to lung cancer screening guidelines
MDedge Hematology and Oncology
ctDNA shows promise for assessing lung cancer treatment response
MDedge Hematology and Oncology
CMS updates lung screening criteria, more aligned with USPSTF
MDedge Hematology and Oncology
Women at higher risk of serious adverse events from cancer therapy
MDedge Hematology and Oncology